Angel News
Angel News

Back to Homepage

4th August 2021

Maven VCTs invest further £500k in GENinCode as company goes to IPO

Maven Capital Partners, one of the UK’s most active private equity houses, has invested a further £500,000 in GENinCode, a genetic testing company specialising in the risk assessment and prediction of cardiovascular disease. This funding package comes as the company completes its IPO, raising an additional £17 million gross and listing on AIM with a market capitalisation of £42.2 million.

2nd August 2021

MMC and Local Globe invest in menopause healthtech

Vira Health, a digital health company focused on improving long-term health for women, has raised £1.5M in seed funding from LocalGlobe, MMC Ventures, and angel investors including Megumi Ikeda, Managing Director, Hearst Ventures, Andrea Zitna of Elvie, former Spotify executive Sofia Bendz, founder of GoCardless Matt Robinson, and Simon Lambert, former CTO,, and Treatwell. 

30th July 2021

Peppy raises £6.6m to scale its personalised  employee healthcare

Peppy, a B2B digital health platform, has announced a £6.6m Series A funding round. Peppy provides tailored, expert-led support to individuals before they need to see a doctor, bridging the gap between online searches and hard-to-access clinical care. The investment was led by Felix Capital with previous investors including Outward VC, Seedcamp, and Hambro Perks, also participating. 

30th July 2021

4D Biomaterials raises £1.6m led by DSW Ventures for 3D printed implants

4D Biomaterials, a medtech company which has developed a new biomaterial used for 3D printing medical implants, has completed a £1.6m funding round led by DSW Ventures.

30th July 2021

Patchwork Health raises £3.5m to end NHS staff burnout

Patchwork Health, the healthcare staffing platform founded by doctors, has raised £3.5m to accelerate their mission to solve the NHS burnout crisis. The funding, from Praetura Ventures and BMJ New Ventures, comes as an NHS workforce 'emergency' is declared and waiting lists reach record highs.

26th July 2021

$25.3m raised for Leo Cancer Care

Leo Cancer Care is an innovative start-up company that is set to change the face of Radiation Therapy forever. They recently completed their Series B fundraising activities, through parent company Asto CT Inc. alongside the team at Pureland Global Venture. The fundraise has seen investments from investors located all across the globe, some of the largest investors in the fundraise alongside Pureland were investment companies Yu Galaxy, WARF, Alumni Ventures, Junson Capital and Serra Ventures as well as industry leaders CHC, Cosylab, Toret Devices and Radiation Business Solutions.

23rd July 2021

Calculus and Foresight successfully exit Mologic

Calculus Capital and Foresight Group have successfully sold Mologic Limited, a world leading innovator in lateral flow and rapid diagnostic technologies, and founder of Global Access Diagnostics. Mologic’s co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the world’s first commercial application of lateral flow technology.

22nd July 2021

Foresight successfully exits Mologic by sale to Global Access Health

Foresight Group LLP, an award-winning listed infrastructure and regional private equity investment manager, has sold Mologic Limited, a World leading innovator in lateral flow and rapid diagnostic technologies and founder of Global Access Diagnostics. Mologics co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the worlds first commercial application of lateral flow technology.

22nd July 2021

TravelPerk cofounder launches mental health startup Oliva

TravelPerk cofounder launches mental health startup Oliva backed by Moonfire Ventures.

21st July 2021

New UK virus killing PPE firm Viracoat raises £2m from Australia

Viracoat, a subsidiary of Viracorp set up to develop and produce PPE that begins killing COVID-19 and other viruses on contact, has raised £2million ($4million Australian dollars) to fund final stages of accreditation and further UK based research. The funding comes from J.J. Richards & Sons Pty Ltd, an Australian, family owned and operated business that provides waste management service solutions throughout Australia and New Zealand and already has a successful scientific and medical distribution subsidiary.

21st July 2021

Tencent invests €29.5m in Sweden's

Sweden’s largest providers of digital healthcare,, has secured €29.5 million from Tencent Holdings.

19th July 2021

‘Revolutionary woundcare’ biotech firm raises £1.8m from MEIF

A biotech company with a product that helps to heal eye injuries and could revolutionise treatment of other wounds has raised a further £1.8m.

Nottingham-based NuVision Biotherapies  has secured funding from the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and part of the Midlands Engine Investment Fund, Mercia’s EIS funds, Newable Ventures and private investors.

Items of 353NEXT

Back to Homepage